Jaguar Health, Inc. (NASDAQ: JAGX) announced the commercial launch of Neonorm Dog, a plant-based, non-prescription product intended to support normal stool consistency and gastrointestinal fluid balance in dogs.

The product extends Jaguar's existing Neonorm franchise, which currently includes Neonorm Foal and Neonorm Calf. Like those products, Neonorm Dog contains a standardized botanical extract derived from the Croton lechleri tree. The company said the product is not intended to diagnose, treat, cure, or prevent any disease, and is not a substitute for veterinary care.

Jaguar said it expects Neonorm Dog to become available through Amazon and Chewy, as well as select animal health retail channels. No specific pricing or availability date was provided in the announcement.

"Neonorm Dog brings Jaguar's longstanding expertise in plant-based gastrointestinal health to the companion animal market," said Ian Wendt, Jaguar's Chief Business Officer, adding that the product is aimed at dog owners seeking a non-antibiotic option to manage episodes of loose stools.

Lisa Conte, Jaguar's founder, president, and CEO, described the product as "a science-backed replacement for uncertain home remedies for digestive support that owners can keep on hand before symptoms start."

The San Francisco-based company said the launch is intended to broaden its commercial presence in the companion animal market.